Ardent Health reported cash from operations of $196.74M and free cash flow of $158.06M for the quarter ended Jun 2026, up 67.4% year over year. This cash flow statement covers 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Net Income | 55.71M | 38.67M | 10.79M | 45.85M | 66.96M | 45.97M | 140.89M | 58.97M | 95.69M | 1.21M | 74.26M | 58.49M | 34.69M |
| Share-based CompensationStock Comp. | 0.18M | 0.18M | 0.51M | 0.23M | 8.13M | 9.11M | 9.26M | 11.25M | 9.67M | 9.11M | 8.93M | 7.95M | |
| Deferred Taxes | 1.46M | -0.59M | 0.32M | -1.24M | 2.61M | 22.35M | -1.94M | -0.79M | 17.62M | 28.71M | -0.43M | 3.50M | |
| Cash from OperationsCash from Ops. | 88.65M | 67.50M | -14.69M | 120.44M | 89.71M | 119.57M | -24.79M | 117.49M | 154.37M | 223.44M | -60.22M | 196.74M | |
| Depreciation, Depletion & Amortization | |||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 1.42M | 0.72M | 1.43M | 1.43M | 1.38M | 1.23M | 1.24M | 1.24M | 1.09M | 0.81M | 0.81M | 0.81M | |
| Depreciation & Amortization (CF)Dep. & Amort. | 35.49M | 35.98M | 35.35M | 36.31M | 36.77M | 37.85M | 36.20M | 39.31M | 39.16M | 41.04M | 42.99M | 41.34M | |
| Change in Working Capital | |||||||||||||
| Change in ReceivablesChange Receivables | 4.50M | 126.20M | -60.33M | -1.69M | -15.26M | 37.28M | 30.72M | -16.47M | -30.84M | -42.56M | -0.03M | 9.87M | |
| Change in InventoryChange Inventory | -0.35M | -2.22M | 0.45M | -0.99M | 3.08M | 6.86M | 5.19M | -2.07M | 3.19M | -3.16M | 1.25M | -3.82M | |
| Change in Accured ExpensesChange Accured Exp. | 9.15M | 153.69M | -115.78M | 29.97M | -46.22M | 28.17M | -80.95M | 30.36M | 30.90M | 81.75M | -65.59M | 5.19M | |
| Investing Activities | |||||||||||||
| Capital ExpendituresCapex | 25.01M | 57.45M | 23.84M | 38.93M | 43.47M | 81.27M | 22.91M | 46.20M | 58.80M | 84.00M | 28.09M | 38.68M | |
| Acquisitions | 7.80M | 0.24M | 27.50M | 2.50M | |||||||||
| Cash from Investing ActivitiesCash from Investing | -24.77M | -56.71M | -31.64M | -38.87M | -44.51M | -105.44M | -23.12M | -46.25M | -58.63M | -86.23M | -27.90M | -39.18M | |
| Financing Activities | |||||||||||||
| Other financing activitiesOther financing | -1.81M | 208.66M | -1.06M | -0.44M | -0.33M | -3.40M | -1.01M | 1.73M | |||||
| Cash from Financing ActivitiesCash from Financing | -23.91M | -17.89M | -18.48M | -119.80M | 183.41M | -20.48M | -13.83M | -25.66M | -26.93M | -37.05M | -11.79M | -42.77M | |
| Dividend Payments | |||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 18.87M | 13.20M | 14.26M | 17.40M | 21.48M | 19.72M | 19.24M | 20.29M | 22.84M | 25.87M | 21.31M | 22.83M | |
| Additional items | |||||||||||||
| Change in Cash | 39.97M | -7.10M | -64.81M | -38.23M | 228.60M | -6.36M | -61.74M | 45.59M | 68.81M | 100.16M | -99.91M | 114.78M | |
| Free Cash FlowFCF | 63.64M | 10.05M | -38.53M | 81.51M | 46.24M | 38.30M | -47.70M | 71.29M | 95.57M | 139.44M | -88.31M | 158.06M | |
| Net Cash FlowNCF | 39.97M | -7.10M | -64.81M | -38.23M | 228.60M | -6.36M | -61.74M | 45.59M | 68.81M | 100.16M | -99.91M | 114.78M |